Article
18 Feb 2026
No More Needles In Haystacks: Congress Requires FDA To Explain Q1/Q2 Sameness
AUTHORS CONTENT
Article
12 Feb 2026
Here We Go Again: Third Round Of Inflation Reduction Act Drugs Listed
Article
04 Jun 2025
FTC Peeling Back The Layers Of The Orange Book
Article
13 Jun 2024
Court Orders Patents Delisted From Orange Book: Is FTC's Newly Aggressive Posture Having An Impact?
Article
08 May 2024
FTC Expands Orange Book Patent Listing Challenges
Article
15 Feb 2024
Lights, Camera, Action: GoPro's Section 101 Arguments Head To The Federal Circuit
Article
22 Dec 2023
The Inflation Reduction Act's First Potential Impact On Biosimilars
Article
21 Dec 2023
FTC Spoke, Kaleo And Impax Listened: Orange Book Patent Delistings Begin
Article
16 Nov 2023
No Voluntary Delistings Or Disputes In FDA's Orange Book Update
Article
11 Sep 2023
Supreme Court Denies Cert. In Skinny Label Case, But The Impacts From GSK v. Teva Continue